Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 198 aa | 28.3 % |
Trichomonas vaginalis | conserved hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 197 aa | 22.3 % |
Onchocerca volvulus | 4'-phosphopantetheinyl transferase ffp | 224 aa | 186 aa | 26.3 % | |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0078 | 0.021 | 0.021 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.01 | 0.0458 | 0.0253 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.0078 | 0.021 | 0.5 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0078 | 0.021 | 0.021 |
Mycobacterium tuberculosis | Probable protease II PtrBb [second part] (oligopeptidase B) | 0.0078 | 0.021 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0458 | 0.0253 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0078 | 0.021 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.1327 | 0.1141 |
Brugia malayi | hypothetical protein | 0.0286 | 0.247 | 0.247 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.0329 | 0.2942 | 0.2791 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.1327 | 0.1141 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.247 | 0.2308 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0078 | 0.021 | 0.5 |
Trichomonas vaginalis | Clan SC, family S9, acylaminoacyl-peptidase-like serine peptidase | 0.0078 | 0.021 | 0.5 |
Schistosoma mansoni | acylaminoacyl-peptidase (S09 family) | 0.0078 | 0.021 | 0.021 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0979 | 1 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.247 | 0.2308 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0078 | 0.021 | 0.021 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.1327 | 0.1141 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.1327 | 0.1141 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0078 | 0.021 | 0.021 |
Onchocerca volvulus | Prolyl endopeptidase homolog | 0.0078 | 0.021 | 0.021 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.0329 | 0.2942 | 0.2942 |
Plasmodium vivax | hypothetical protein, conserved | 0.0078 | 0.021 | 0.5 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.0329 | 0.2942 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.247 | 0.2308 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0078 | 0.021 | 0.5 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0078 | 0.021 | 0.5 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0979 | 1 | 1 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.0329 | 0.2942 | 1 |
Brugia malayi | hypothetical protein | 0.0251 | 0.2099 | 0.2099 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.01 | 0.0458 | 0.0458 |
Onchocerca volvulus | 0.01 | 0.0458 | 0.0458 | |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.0329 | 0.2942 | 1 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0078 | 0.021 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0078 | 0.021 | 0.021 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.01 | 0.0458 | 0.0253 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0979 | 1 | 1 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.0329 | 0.2942 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0251 | 0.2099 | 0.193 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0979 | 1 | 1 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0078 | 0.021 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0078 | 0.021 | 0.021 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0078 | 0.021 | 0.5 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.01 | 0.0458 | 0.0458 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.0329 | 0.2942 | 0.2791 |
Plasmodium falciparum | peptidase, putative | 0.0078 | 0.021 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.1327 | 0.1141 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0078 | 0.021 | 0.5 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.0979 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0078 | 0.021 | 0.5 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0078 | 0.021 | 0.5 |
Mycobacterium tuberculosis | Probable peptidase | 0.0078 | 0.021 | 0.5 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.0329 | 0.2942 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0078 | 0.021 | 0.5 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.0329 | 0.2942 | 1 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.1327 | 0.1327 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0329 | 0.2942 | 0.2942 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7375 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 0.8913 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 19.9526 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.